Credit Suisse Sees Everyday Health Dipping Into The Long Tail

In a report published Tuesday, Credit Suisse analyst Stephen Ju reiterated an Outperform rating and $23.00 price target on

. In the report, Credit Suisse noted, "EVDY reported 4Q14 results with revenue of $63m versus consensus and CS $63.0m. Adjusted EBITDA of $18.7m was above consensus $18.0m and CS $18.1m. Advertising Revenue was $59m vs. CS $58.6m. Management offered 1Q15 and FY15 guidance for revenue and adj. EBITDA for $39m–$41m/($0.5m) -$0.5m and $221m–$228m/$46m-$49m, respectively. Our FY15 EPS is now $0.63 (vs. prior $0.84)." Everyday Health closed on Monday at $14.75.